Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 9/20 | 0.44 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.38 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7084270 | 0.89 | PTGS2 (0.44) | PTGS2ITGB1ITGA4 | |
| SCHEMBL7085231 | 0.88 | PTGS2 (0.48) | PTGS2 | |
| SCHEMBL7089401 | 0.84 | SMN1; SMN2 (0.37) | — | |
| SCHEMBL7087484 | 0.83 | PTGS2 (0.41) | PTGS2 | |
| SCHEMBL7091359 | 0.81 | PTGS2 (0.45) | PTGS2 | |
| SCHEMBL7089294 | 0.77 | PTGS2 (0.43) | PTGS2 | |
| SCHEMBL7493557 | 0.76 | PTGS2 (0.49) | PTGS2ITGB1ITGA4 | |
| SCHEMBL7083940 | 0.76 | PTGS2 (0.45) | PTGS2 | |
| SCHEMBL7085149 | 0.76 | PTGS2 (0.40) | PTGS2 | |
| SCHEMBL7084272 | 0.76 | CES2 (0.50) | PTGS2ITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0772601-B1 | 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2002-09-18 | — | — | EP | disclosed |
| US-6426360-B1 | ANTIARTHRITIC AGENTS | G D SEARLE & CO. | 2002-07-30 | — | — | US | disclosed |
| EP-1211244-A2 | 4,5-substitued imidazolyl compounds for the treatment of inflammation | G.D. Searle & Co. (US) | 2002-06-05 | — | — | EP | disclosed |
| WO-1996003387-A1 | 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-02-08 | — | — | WO | disclosed |